Immunoblots were performed as described (Bourseguin et al., 2016 (link)). The antibodies used were: mouse monoclonal anti-FANCM antibody (CV5.1, Novus biologicals, Abingdon, UK) (RRID:AB_2716711), mouse monoclonal anti-FANCD2, (Santa-Cruz Biotechnology, Dallas, Texas, USA, SC-20022) (RRID:AB_2278211), rabbit anti-FANCA (Abcam) (Bethyl Laboratories, Montgomeryn Texas, USA, Cat# A301-980A RRID:AB_1547945), mouse anti-vinculin (Abcam) (RRID:AB_11156698), Rabbit anti-CHK1 antibody from Santa-Cruz Biotechnology (SC-8408) (RRID:AB_627257), mouse monoclonal anti-Phospho-CHK1 (Ser317) antibody from Cell Signaling Technology (#2344) (RRID:AB_331488), monoclonal anti-phospho-H2AX (Ser139) antibody from Millipore (RRID:AB_309864). To transiently deplete FANCM, HEK293 cells (RRID:CVCL_0045) were transfected with 20 nmol/L of small INTERFERing RNA (siRNA) targeting FANCM, 5'-GGC-UAC-GUC-CAG-GAG-CGC-3' with 8 μL INTERFERin (Polyplus) in Opti-MEM. The protein bands were visualized and recorded using an ImageQuant apparatus. Western blot quantifications were performed using densitometry measures and the ImageJ software.
Free full text: Click here